Investing in Healthcare Innovation
At MPM, we focus equally on capturing and creating value. We capture value by identifying under-appreciated assets and by understanding risk. We "create" value by doing whatever it takes to help our companies succeed.
Latest News
May 07, 2012 BV 4 Portfolio Company Celladon Corporation Completes Second Close of Recent Venture Financing
Apr 23, 2012 BV 4 Portfolio Company Syndax Pharmaceuticals Appoints Arlene Morris as CEO
Apr 12, 2012 BV 4 Portfolio Company Pacira Pharmaceuticals, Inc. Prices Public Offering of Common Stock
Mar 30, 2012 Former Portfolio Company Affymax and Takeda Announce FDA Approval of OMONTYS
